Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
5.00
+0.07 (1.52%)
At close: Mar 6, 2026, 4:00 PM EST
5.26
+0.26 (5.10%)
After-hours: Mar 6, 2026, 6:49 PM EST
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $187.40 million as of March 6, 2026. Its market cap has increased by 1.85% in one year.
Market Cap
187.40M
Enterprise Value
55.08M
1-Year Change
1.85%
Ranking
Category
Stock Price
$5.00
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $187.40M, a decrease of -68.53%. That is a compound annual growth rate of -13.39%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 195.24M |
| Compugen | 194.55M |
| Tenaya Therapeutics | 192.26M |
| NeOnc Technologies Holdings | 188.04M |
| ProQR Therapeutics | 187.51M |
| Kalaris Therapeutics | 183.66M |
| Heron Therapeutics | 182.24M |
| SAB Biotherapeutics | 180.43M |